Filana Therapeutics Stock Price, News & Analysis
Company Description
Filana Therapeutics (NASDAQ: FLNA) is a publicly traded biotechnology company in the Pharmaceutical Preparations sector. The company has a market capitalization of $88.4M, ranking #5,163 among all listed U.S. companies by market cap.
FLNA stock has declined 14.3% over the past year. Shares last traded at $1.79.
On a trailing twelve-month basis, Filana Therapeutics reported net income of -$91.0M and diluted earnings per share of $-1.88.
This page provides a comprehensive overview of FLNA stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Filana Therapeutics (FLNA) stock last traded at $1.79, up 0.55% from the previous close. Over the past 12 months, the stock has lost 14.3%. At a market capitalization of $88.4M, FLNA is classified as a micro-cap stock with approximately 48.3M shares outstanding.
Latest News
Filana Therapeutics has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include earnings. View all FLNA news →
SEC Filings
Financial Highlights
operating income reached -$95.4M, and net income was -$91.0M. Diluted earnings per share stood at $-1.88. The company generated -$32.3M in operating cash flow. With a current ratio of 2.23, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Days to Cover History
FLNA Company Profile & Sector Positioning
Filana Therapeutics (FLNA) operates in the Biotechnology industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.